Literature DB >> 22586035

A switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-γ-inducible lysosomal thiol reductase-free mice.

Cheryl M Bergman1, Cecilia B Marta, Maja Maric, Steven E Pfeiffer, Peter Cresswell, Nancy H Ruddle.   

Abstract

IFN-γ-inducible lysosomal thiol reductase (GILT) is an enzyme located in the Lamp-2-positive compartments of APC. GILT(-/-) mice are phenotypically normal, but their T cells exhibit reduced proliferation to several exogenously administered Ags that include cysteine residues and disulfide bonds. We undertook the present studies to determine if GILT(-/-) mice would process exogenously administered myelin oligodendrocyte glycoprotein (MOG), which contains disulfide bonds, to generate experimental autoimmune encephalomyelitis (EAE) to the endogenous protein. One possibility was that MOG(35-55) peptide would induce EAE, but that MOG protein would not. GILT(-/-) mice were relatively resistant to MOG(35-55)-induced EAE but slightly more susceptible to rat MOG protein-induced EAE than wild-type (WT) mice. Even though MOG(35-55) was immunogenic in GILT(-/-) mice, GILT APCs could not generate MOG(35-55) from MOG protein in vitro, suggesting that the endogenous MOG protein was not processed to the MOG(35-55) peptide in vivo. Immunization of GILT(-/-) mice with rat MOG protein resulted in a switch in pathogenic mechanism from that seen in WT mice; the CNS infiltrate included large numbers of plasma cells; and GILT(-/-) T cells proliferated to peptides other than MOG(35-55). In contrast to WT rat MOG-immunized mice, rat MOG-immunized GILT(-/-) mice generated Abs that transferred EAE to MOG(35-55)-primed GILT(-/-) mice, and these Abs bound to oligodendrocytes. These studies, demonstrating the key role of a processing enzyme in autoimmunity, indicate that subtle phenotypic changes have profound influences on pathogenic mechanisms and are directly applicable to the outbred human population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22586035      PMCID: PMC4133136          DOI: 10.4049/jimmunol.1101898

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT).

Authors:  B Arunachalam; U T Phan; H J Geuze; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.

Authors:  Cecilia B Marta; Alfred R Oliver; Rebecca A Sweet; Steven E Pfeiffer; Nancy H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

3.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide.

Authors:  J A Lyons; M San; M P Happ; A H Cross
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

Review 5.  Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.

Authors:  Christine Stadelmann
Journal:  Curr Opin Neurol       Date:  2011-06       Impact factor: 5.710

Review 6.  Treatment of multiple sclerosis with anti-CD20 antibodies.

Authors:  Barbara Barun; Amit Bar-Or
Journal:  Clin Immunol       Date:  2011-04-15       Impact factor: 3.969

7.  Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis.

Authors:  Cecilia B Marta; Michael B Montano; Christopher M Taylor; Ava L Taylor; Rashmi Bansal; Steven E Pfeiffer
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

8.  De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

Authors:  Stephen Mark Tompkins; Josette Padilla; Mauro C Dal Canto; Jenny P-Y Ting; Luc Van Kaer; Stephen D Miller
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

9.  Defective antigen processing in GILT-free mice.

Authors:  M Maric; B Arunachalam; U T Phan; C Dong; W S Garrett; K S Cannon; C Alfonso; L Karlsson; R A Flavell; P Cresswell
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

10.  Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes.

Authors:  M Azizul Haque; Ping Li; Sheila K Jackson; Hassane M Zarour; John W Hawes; Uyen T Phan; Maja Maric; Peter Cresswell; Janice S Blum
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

View more
  10 in total

1.  Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120.

Authors:  Hong-Nam P Nguyen; N Kalaya Steede; James E Robinson; Samuel J Landry
Journal:  Vaccine       Date:  2015-05-02       Impact factor: 3.641

Review 2.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

Review 3.  Diverse cellular and organismal functions of the lysosomal thiol reductase GILT.

Authors:  Matthew P Rausch; Karen Taraszka Hastings
Journal:  Mol Immunol       Date:  2015-06-23       Impact factor: 4.407

4.  Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.

Authors:  Debayon Paul; Ann E Cowan; Shujun Ge; Joel S Pachter
Journal:  Microvasc Res       Date:  2012-12-20       Impact factor: 3.514

Review 5.  GILT: Shaping the MHC Class II-Restricted Peptidome and CD4(+) T Cell-Mediated Immunity.

Authors:  Karen Taraszka Hastings
Journal:  Front Immunol       Date:  2013-12-04       Impact factor: 7.561

6.  Low GILT Expression is Associated with Poor Patient Survival in Diffuse Large B-Cell Lymphoma.

Authors:  Hannah Phipps-Yonas; Haiyan Cui; Noemi Sebastiao; Patrick S Brunhoeber; Ellen Haddock; Martin J Deymier; Wolfram Klapper; Lonnie Lybarger; Denise J Roe; Karen Taraszka Hastings
Journal:  Front Immunol       Date:  2013-12-04       Impact factor: 7.561

Review 7.  Translational utility of experimental autoimmune encephalomyelitis: recent developments.

Authors:  Andre Ortlieb Guerreiro-Cacais; Hannes Laaksonen; Sevasti Flytzani; Marie N'diaye; Tomas Olsson; Maja Jagodic
Journal:  J Inflamm Res       Date:  2015-11-13

8.  Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.

Authors:  Satoru Oji; Eva-Maria Nicolussi; Nathalie Kaufmann; Bleranda Zeka; Kathrin Schanda; Kazuo Fujihara; Zsolt Illes; Charlotte Dahle; Markus Reindl; Hans Lassmann; Monika Bradl
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

9.  A non-immunological role for γ-interferon-inducible lysosomal thiol reductase (GILT) in osteoclastic bone resorption.

Authors:  Benjamin W Ewanchuk; Corey R Arnold; Dale R Balce; Priyatha Premnath; Tanis L Orsetti; Amy L Warren; Alexandra Olsen; Roman J Krawetz; Robin M Yates
Journal:  Sci Adv       Date:  2021-04-23       Impact factor: 14.136

Review 10.  Expanding roles for GILT in immunity.

Authors:  Laura Ciaccia West; Peter Cresswell
Journal:  Curr Opin Immunol       Date:  2012-12-12       Impact factor: 7.486

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.